BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24918581)

  • 21. MicroRNA-155 promotes the proliferation and invasion abilities of colon cancer cells by targeting quaking.
    He B; Gao SQ; Huang LD; Huang YH; Zhang QY; Zhou MT; Shi HQ; Song QT; Shan YF
    Mol Med Rep; 2015 Mar; 11(3):2355-9. PubMed ID: 25420938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
    Berezovsky AD; Poisson LM; Cherba D; Webb CP; Transou AD; Lemke NW; Hong X; Hasselbach LA; Irtenkauf SM; Mikkelsen T; deCarvalho AC
    Neoplasia; 2014 Mar; 16(3):193-206, 206.e19-25. PubMed ID: 24726753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NONO Is a Negative Regulator of
    Liang S; Takahashi H; Hirose T; Kuramitsu Y; Hatakeyama S; Yoshiyama H; Wang R; Hamada JI; Iizasa H
    Cancer Genomics Proteomics; 2020; 17(4):359-367. PubMed ID: 32576581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
    Kim EJ; Kim JS; Lee S; Lee H; Yoon JS; Hong JH; Chun SH; Sun S; Won HS; Hong SA; Kang K; Jo JY; Choi M; Shin DH; Ahn YH; Ko YH
    Int J Cancer; 2019 Sep; 145(6):1585-1595. PubMed ID: 31026342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity.
    Nakatsugawa M; Takahashi A; Hirohashi Y; Torigoe T; Inoda S; Murase M; Asanuma H; Tamura Y; Morita R; Michifuri Y; Kondo T; Hasegawa T; Takahashi H; Sato N
    Lab Invest; 2011 Dec; 91(12):1796-804. PubMed ID: 21931300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
    Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
    Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
    Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
    J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
    Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
    Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
    Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
    Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced O-GlcNAc modification induced by the RAS/MAPK/CDK1 pathway is required for SOX2 protein expression and generation of cancer stem cells.
    Shimizu M; Shibuya H; Tanaka N
    Sci Rep; 2022 Feb; 12(1):2910. PubMed ID: 35190631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
    Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
    Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-214 regulates smooth muscle cell differentiation from stem cells by targeting RNA-binding protein QKI.
    Wu Y; Li Z; Yang M; Dai B; Hu F; Yang F; Zhu J; Chen T; Zhang L
    Oncotarget; 2017 Mar; 8(12):19866-19878. PubMed ID: 28186995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma.
    Sacco A; Battaglia AM; Santamaria G; Buffone C; Barone S; Procopio A; Lavecchia AM; Aversa I; Giorgio E; Petriaggi L; Cristofaro MG; Biamonte F; Giudice A
    PLoS One; 2023; 18(12):e0293475. PubMed ID: 38096163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties.
    Liu J; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R; Zhou Y
    Int J Oncol; 2013 Feb; 42(2):453-9. PubMed ID: 23229446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MSX2 represses tumor stem cell phenotypes within oral squamous cell carcinomas via SOX2 degradation.
    Keyimu R; Tuerdi M; Zhao Z
    Exp Biol Med (Maywood); 2021 Dec; 246(24):2660-2670. PubMed ID: 34435915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.
    Yin Y; Xie CM; Li H; Tan M; Chen G; Schiff R; Xiong X; Sun Y
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20528-20538. PubMed ID: 31548378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
    Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Kobayashi J; Sasaki T; Fujino J; Asanuma H; Tamura Y; Nakamori K; Hasegawa T; Hiratsuka H; Sato N
    Pathol Int; 2012 Oct; 62(10):684-9. PubMed ID: 23005595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties.
    Lee CR; Lee SH; Rigas NK; Kim RH; Kang MK; Park NH; Shin KH
    Carcinogenesis; 2016 Feb; 37(2):119-128. PubMed ID: 26645717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumor suppressing effects of QKI-5 in prostate cancer: a novel diagnostic and prognostic protein.
    Zhao Y; Zhang G; Wei M; Lu X; Fu H; Feng F; Wang S; Lu W; Wu N; Lu Z; Yuan J
    Cancer Biol Ther; 2014 Jan; 15(1):108-18. PubMed ID: 24153116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.